Exploring a new approach to help people who inject drugs access HIV prevention and treatment.
Impact of a novel HIV peer navigationand overdose prevention intervention on engagement in the HIV prevention and treatment cascade.
This study is looking at how having a supportive buddy system and overdose prevention can help people who inject drugs get better access to HIV prevention and treatment, including wound care and PrEP, to keep them healthier and safer.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-11100717 on NIH RePORTER |
What this research studies
This research investigates how a peer navigation and overdose prevention intervention can improve engagement in HIV prevention and treatment for people who inject drugs (PWID). It aims to integrate wound care services into existing substance use programs, addressing barriers that PWID face in accessing healthcare. By providing support and resources, the intervention seeks to increase the uptake of pre-exposure prophylaxis (PrEP) among this high-risk population. The study will evaluate the effectiveness of this combined approach in reducing HIV risk behaviors and improving health outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who inject drugs and are at high risk for HIV infection.
Not a fit: Patients who do not inject drugs or are not at risk for HIV may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly increase access to HIV prevention and treatment for people who inject drugs, ultimately reducing HIV transmission rates.
How similar studies have performed: Previous research has shown that integrating healthcare services into substance use programs can improve health outcomes, suggesting that this approach may be effective.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Sherman, Susan G. — Johns Hopkins University
- Study coordinator: Sherman, Susan G.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.